03759.HK
Pharmaron Beijing Co., Ltd.
HKSE · Healthcare · Biotechnology · CN
HKD 29.00
−2.03%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
16.6x
EV/EBITDA
19.4x
Market Cap
HKD 52.29B
MomentumView details →
1D Return
−2.03%
YTD Return
+48.03%
RSI (14)
52.6
ValuationView details →
P/E (Fwd)
16.6x
EV/EBITDA
19.4x
Market Cap
HKD 52.29B
RSI (14)
52.6
MomentumView details →
1D Return
−2.03%
YTD Return
+48.03%
Similar companies
Latest newsMore news →
Pharmaceutical R&D service company Pharmaron (03759) announced the proposed issuance of RMB 2.18 billion zero-coupon convertible bonds due 2027, priced at 102% of principal, with net proceeds of approximately USD 327.2 million to be used for business expansion, debt refinancing, and general corporate purposes.9d agoAI² Robotics and Pharmaron signed a strategic partnership agreement to combine AI² Robotics' embodied large model technology with Pharmaron's life sciences expertise, focusing on deploying embodied intelligence in pharmaceutical R&D and building smart lab ecosystems.9d ago